Sirt1 protects against high-fat diet-induced metabolic damage

被引:790
作者
Pfluger, Paul T. [2 ]
Herranz, Daniel [1 ]
Velasco-Miguel, Susana [1 ]
Serrano, Manuel [1 ]
Tschop, Matthias H. [2 ]
机构
[1] Spanish Natl Canc Res Ctr, CNIO, Madrid 28029, Spain
[2] Univ Cincinnati, Coll Med, Genome Res Inst, Dept Psychiat,Obes Res Ctr, Cincinnati, OH 45237 USA
关键词
inflammation; metabolism; NF kappa B; sirtuins; steatosis;
D O I
10.1073/pnas.0802917105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The identification of new pharmacological approaches to effectively prevent, treat, and cure the metabolic syndrome is of crucial importance. Excessive exposure to dietary lipids causes inflammatory responses, deranges the homeostasis of cellular metabolism, and is believed to constitute a key initiator of the metabolic syndrome. Mammalian Sirt1 is a protein deacetylase that has been involved in resveratrol-mediated protection from high-fat diet-induced metabolic damage, but direct proof for the implication of Sirt1 has remained elusive. Here, we report that mice with moderate overexpression of Sirt1 under the control of its natural promoter exhibit fat mass gain similar to wild-type controls when exposed to a high-fat diet. Higher energy expenditure appears to be compensated by a parallel increase in food intake. Interestingly, transgenic Sirt1 mice under a high-fat diet show lower lipid-induced inflammation along with better glucose tolerance, and are almost entirely protected from hepatic steatosis. We present data indicating that such beneficial effects of Sirt1 are due to at least two mechanisms: induction of antioxidant proteins MnSOD and Nrf1, possibly via stimulation of PGC1 alpha, and lower activation of proinflammatory cytokines, such as TNF alpha and IL-6, via down-modulation of NF kappa B activity. Together, these results provide direct proof of the protective potential of Sirt1 against the metabolic consequences of chronic exposure to a high-fat diet.
引用
收藏
页码:9793 / 9798
页数:6
相关论文
共 43 条
[1]   Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD) [J].
Ahmed, Mohamed H. ;
Byrne, Christopher D. .
DRUG DISCOVERY TODAY, 2007, 12 (17-18) :740-747
[2]   Sirt1 regulates aging and resistance to oxidative stress in the heart [J].
Alcendor, Ralph R. ;
Gao, Shumin ;
Zhai, Peiyong ;
Zablocki, Daniela ;
Holle, Eric ;
Yu, Xianzhong ;
Tian, Bin ;
Wagner, Thomas ;
Vatner, Stephen F. ;
Sadoshima, Junichi .
CIRCULATION RESEARCH, 2007, 100 (10) :1512-1521
[3]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[4]   Resveratrol improves health and survival of mice on a high-calorie diet [J].
Baur, Joseph A. ;
Pearson, Kevin J. ;
Price, Nathan L. ;
Jamieson, Hamish A. ;
Lerin, Carles ;
Kalra, Avash ;
Prabhu, Vinayakumar V. ;
Allard, Joanne S. ;
Lopez-Lluch, Guillermo ;
Lewis, Kaitlyn ;
Pistell, Paul J. ;
Poosala, Suresh ;
Becker, Kevin G. ;
Boss, Olivier ;
Gwinn, Dana ;
Wang, Mingyi ;
Ramaswamy, Sharan ;
Fishbein, Kenneth W. ;
Spencer, Richard G. ;
Lakatta, Edward G. ;
Le Couteur, David ;
Shaw, Reuben J. ;
Navas, Placido ;
Puigserver, Pere ;
Ingram, Donald K. ;
de Cabo, Rafael ;
Sinclair, David A. .
NATURE, 2006, 444 (7117) :337-342
[5]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[6]   SIRT1 transgenic mice show phenotypes resembling calorie restriction [J].
Bordone, Laura ;
Cohen, Dena ;
Robinson, Ashley ;
Motta, Maria Carla ;
van Veen, Ed ;
Czopik, Agnieszka ;
Steele, Andrew D. ;
Crowe, Hayley ;
Marmor, Stephen ;
Luo, Jianyuan ;
Gu, Wei ;
Guarente, Leonard .
AGING CELL, 2007, 6 (06) :759-767
[7]   Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[8]   Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice [J].
Cheng, HL ;
Mostoslavsky, R ;
Saito, S ;
Manis, JP ;
Gu, YS ;
Patel, P ;
Bronson, R ;
Appella, E ;
Alt, FW ;
Chua, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10794-10799
[9]   The hormonal control of food intake [J].
Coll, Anthony P. ;
Farooqi, I. Sadaf ;
O'Rahilly, Stephen .
CELL, 2007, 129 (02) :251-262
[10]   The obesity pipeline: current strategies in the development of anti-obesity drugs [J].
Cooke, Dunstan ;
Bloom, Steve .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (11) :919-931